Crossmark

European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)

Crossref DOI link: https://doi.org/10.1186/s13023-018-0850-2

Published Online: 2018-08-15

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shovlin, Claire L. https://orcid.org/0000-0001-9007-5775
Buscarini, Elisabetta

Kjeldsen, Anette D.

Mager, Hans Jurgen

Sabba, Carlo

Droege, Freya

Geisthoff, Urban

Ugolini, Sara

Dupuis-Girod, Sophie
License Information

Text and Data Mining valid from 2018-08-15
More Information

Article History

Received: 12 February 2018

Accepted: 20 June 2018

First Online: 15 August 2018

Authors’ information

: CLS is the Chair, SDG is the CoChair and EB the Deputy CoChair of VASCERN HHT. The Outcome measures were developed by the HHT WG between March and June 2016. The discussion text was developed during monthly telecons, face to face meeting and by email October 2017–February 2018.

: Not applicable

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.